A comprehensive view of Approved Drugs / Devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca, MSD report UK Medicines & Healthcare Regulatory Agency approves Lynparza Olaparib in combination with abiraterone and prednisone or prednisolone to treat metastatic castration-resistant prostate cancer
Published: March 20, 2023 by PharmaTimes
BD receives FDA 510k clearance for BD Vaginal Panel on the BD COR System; the diagnostic test detects the three most common infectious causes of vaginitis using BD's high-throughput molecular diagnostic platform for large laboratories
Published: March 16, 2023 by Associated Press
Pfizer and BioNTech receive US emergency use authorization of Omicron BA.4/BA.5-adapted bivalent COVID-19 booster in children under 5 years
Published: March 15, 2023 by U.S. Regulated Equity Markets (Alternative Disclosure) via PUBT
FDA approves Pfizer’s Zavzpret zavegepant nasal spray for migraines with and without aura that may relieve symptoms within 30 minutes; relief from migraine lasted up to 48 hours for many patients in clinical trial
Published: March 10, 2023 by USA Today Online
FDA approves single-dose autoinjector of biosimilar egfilgrastim-cbqv Udenyca for patients undergoing myelosuppressive chemotherapy; single-dose allows for at-home or in-office administration the day after chemotherapy
Published: March 09, 2023 by Oncology Nursing News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count